No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs564007538 |
chr20:15301250-15301251 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs112623629 |
chr20:15301268-15301269 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs530977198 |
chr20:15301291-15301292 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs543213325 |
chr20:15301298-15301299 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs113331012 |
chr20:15301299-15301300 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs561287943 |
chr20:15301371-15301372 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs528805917 |
chr20:15301382-15301383 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs577716880 |
chr20:15301414-15301415 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs546959340 |
chr20:15301440-15301441 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs546074850 |
chr20:15301443-15301444 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs532758356 |
chr20:15301450-15301451 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs190903442 |
chr20:15301464-15301465 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs569416076 |
chr20:15301465-15301466 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs76185035 |
chr20:15301503-15301504 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs536708736 |
chr20:15301535-15301536 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs563108359 |
chr20:15301614-15301615 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs62205202 |
chr20:15301621-15301622 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs183941079 |
chr20:15301741-15301742 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs114294200 |
chr20:15301794-15301795 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs138148667 |
chr20:15301813-15301814 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs548923177 |
chr20:15301908-15301909 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs376157809 |
chr20:15301980-15301981 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs186805254 |
chr20:15302001-15302002 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs578103367 |
chr20:15302046-15302047 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs115165013 |
chr20:15302100-15302101 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs117150903 |
chr20:15302261-15302262 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs527672148 |
chr20:15302309-15302310 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs372997142 |
chr20:15302438-15302439 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs191764327 |
chr20:15302452-15302453 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs149543954 |
chr20:15302488-15302489 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs183110452 |
chr20:15302492-15302493 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs540963941 |
chr20:15302522-15302523 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs565235516 |
chr20:15302572-15302573 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs532621844 |
chr20:15302585-15302586 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs536632433 |
chr20:15302654-15302655 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs187137211 |
chr20:15302714-15302715 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs569276750 |
chr20:15302780-15302781 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs117493779 |
chr20:15302793-15302794 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs199846303 |
chr20:15302858-15302859 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs548787971 |
chr20:15302881-15302882 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs2423921 |
chr20:15302888-15302889 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
42 |
rs377359200 |
chr20:15302897-15302898 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs573372855 |
chr20:15302948-15302949 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs571572872 |
chr20:15302977-15302978 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs559015455 |
chr20:15302979-15302980 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs538899370 |
chr20:15303013-15303014 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs557410146 |
chr20:15303037-15303038 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs144128072 |
chr20:15303173-15303174 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs535334849 |
chr20:15303178-15303179 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs536789758 |
chr20:15303207-15303208 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|